安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Palbociclib - Wikipedia
Palbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6
- Palbociclib: Uses, Dosage, Side Effects, Warnings - Drugs. com
Palbociclib is used to treat adult patients with HR-positive, HER2-negative advanced or metastatic breast cancer It should always be used in combination with another medicine either: fulvestrant in patients with disease progression following endocrine therapy The most common side effects of palbociclib are:
- Palbociclib (Ibrance): Uses Side Effects - Cleveland Clinic
Palbociclib is a medication that stops cancer cells from growing It treats breast cancer This type of cancer occurs when cells in your breast grow and divide in an uncontrolled way, creating a mass of tissue called a tumor
- Ibrance (palbociclib) dosing, indications, interactions, adverse . . .
Medscape - Breast cancer dosing for Ibrance (palbociclib), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy lactation schedules, and cost information
- Palbociclib: Breast Cancer Treatment Uses, Side Effects, Warnings
Palbociclib is a chemotherapy drug used to treat HER2-negative and HR-positive breast cancers in women and men, which are advanced or have spread to other organs (metastatic), in combination with an anti-estrogenic drug Palbociclib can cause fetal harm as well as male infertility
- Ibrance (palbociclib) - Uses, Side Effects, and More
It treats breast cancer that is advanced or has spread to other parts of the body (metastatic) and is hormone receptor (HR)-positive and human epidermal growth factor receptor 2
- Palbociclib - NCI - National Cancer Institute
Palbociclib works by blocking the activity of proteins called CDK4 and CDK6 that control how fast cells grow Blocking these proteins may slow or stop the growth of cancer cells Palbociclib is a type of targeted therapy drug called a kinase inhibitor
- Palbociclib (oral route) - Mayo Clinic
Palbociclib is used to treat hormone receptor (HR)-positive, HER-2 negative advanced or metastatic (cancer that has spread) breast cancer This medicine is used in combination with an aromatase inhibitor (eg, letrozole) as first hormonal based treatment or with fulvestrant in patients with disease progression following hormonal treatment
|
|
|